NEW
Pagenax

Pagenax ATC Classification

Manufacturer:

Novartis

Distributor:

DKSH
Full Prescribing Info
ATC Classification
S01LA06 - brolucizumab ; Belongs to the class antineovasculatisation agents. Used in the management of neovascular macular degeneration.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in